GABA Pathways in Autism Spectrum Disorder (ASD)

NACompletedINTERVENTIONAL

Enrollment

109

Participants

Timeline

Start Date

December 7, 2018

Primary Completion Date

June 27, 2025

Study Completion Date

June 27, 2025

Conditions

Autism Spectrum Disorder

Interventions

DRUG

AZD7325_10

Single oral dose (10mg)

DRUG

AZD7325_20

Single oral dose (20mg)

DRUG

Placebo

Single oral dose placebo (capsule)

DRUG

Clobazam

Single dose (5mg)

Trial Locations (1)

King's College London, London

All Listed Sponsors

lead

King's College London

OTHER

NCT03678129 - GABA Pathways in Autism Spectrum Disorder (ASD) | Biotech Hunter | Biotech Hunter